Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 15, 2020
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
[ Thu, Oct 15th 2020
] - WOPRAI
Robyn Karnauskas Maintained (VRTX) at Strong Buy with Decreased Target to $305 on, Oct 15th, 2020
Robyn Karnauskas of Truist Securities, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Decreased Target from $330 to $305 on, Oct 15th, 2020.
Robyn has made no other calls on VRTX in the last 4 months.
There are 8 other peers that have a rating on VRTX. Out of the 8 peers that are also analyzing VRTX, 2 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $281 on, Tuesday, October 13th, 2020
- Brian Abrahams of "RBC Capital" Maintained at Hold and Held Target at $276 on, Sunday, October 4th, 2020
These are the ratings of the 6 analyists that currently disagree with Robyn
- Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $305 on, Friday, July 31st, 2020
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $315 on, Friday, July 31st, 2020
- Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $309 on, Friday, July 31st, 2020
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $315 on, Friday, July 31st, 2020
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $328 on, Monday, July 20th, 2020
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $330 on, Thursday, July 2nd, 2020
